Boothbay Fund Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Boothbay Fund Management’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-301,939	Closed	-$519K	–	2076
2023 Q3	$519K	Hold	301,939	–	–	0.01%	1018
2023 Q2	$589K	Buy	301,939 +53,085	+21%	+$124K	0.01%	1024
2023 Q1	$692K	Buy	248,854 +220,744	+785%	+$631K	0.01%	1148
2022 Q4	$97K	Buy	+28,110	New	+$80.3K	﹤0.01%	1794
2022 Q3	–	Sell	-14,097	Closed	-$34K	–	2685
2022 Q2	$34K	Buy	+14,097	New	+$37K	﹤0.01%	2135
2019 Q2	–	Sell	-16,000	Closed	-$213K	–	932
2019 Q1	$213K	Buy	+16,000	New	+$214K	0.02%	591

Other funds holding GRTS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Boothbay Fund Management's GRTS Position: Q4 2023 in Review

Boothbay Fund Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2023, closing a stake of 301,939 shares — an estimated $519K sold.

Boothbay Fund Management first reported a position in GRTS in Q1 2019 and held it in 6 quarters. The position peaked at $692K in Q1 2023. 88 funds tracked by Wall St. Rank hold GRTS as of Q4 2023.

Boothbay Fund Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Boothbay Fund Management sold 301,939 Gritstone bio, Inc. Common Stock shares in Q4 2023, an estimated $519K.
Boothbay Fund Management first reported a position in Gritstone bio, Inc. Common Stock in Q1 2019 and held it in 6 quarters.
Boothbay Fund Management's Gritstone bio, Inc. Common Stock position peaked at $692K in Q1 2023.
88 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2023.

Based on Boothbay Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.